Sun Pharma’s Leqselvi faces legal challenges in US launch
Sun Pharmaceutical Industries Ltd’s alopecia drug Leqselvi (Deuruxolitinib) approved by the US Food and Drug Administration (USFDA) earlier this month could see immediate legal hurdles when it comes to its launch. A motion seeking a preliminary injunction has been filed in a US court to prevent the product’s launch. The management cannot comment on the…